Cite
Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors
MLA
Dimitris Karagiannis, et al. “Metabolic Reprogramming by Histone Deacetylase Inhibition Preferentially Targets NRF2-Activated Tumors.” Cell Reports, vol. 43, no. 1, Jan. 2024. EBSCOhost, https://doi.org/10.1016/j.celrep.2023.113629.
APA
Dimitris Karagiannis, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, Xinjing Xu, Francisco J. Sánchez-Rivera, Yadira M. Soto-Feliciano, Jiangbin Ye, Thales Papagiannakopoulos, & Chao Lu. (2024). Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors. Cell Reports, 43(1). https://doi.org/10.1016/j.celrep.2023.113629
Chicago
Dimitris Karagiannis, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, et al. 2024. “Metabolic Reprogramming by Histone Deacetylase Inhibition Preferentially Targets NRF2-Activated Tumors.” Cell Reports 43 (1). doi:10.1016/j.celrep.2023.113629.